PubRank

Dana P Goldman

Author PubWeight™ 92.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Employer drug benefit plans and spending on prescription drugs. JAMA 2002 6.02
2 Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003 4.77
3 Differences in life expectancy due to race and educational differences are widening, and many may not catch up. Health Aff (Millwood) 2012 4.36
4 Forecasting the nursing home population. Med Care 2003 3.11
5 Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data. Ann Intern Med 2010 2.93
6 An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer. Health Aff (Millwood) 2012 2.16
7 Heterogeneity in action: the role of passive personalization in comparative effectiveness research. Health Econ 2013 2.04
8 Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood) 2013 2.03
9 Aging in America in the twenty-first century: demographic forecasts from the MacArthur Foundation Research Network on an Aging Society. Milbank Q 2009 1.89
10 Are the young becoming more disabled? Health Aff (Millwood) 2004 1.88
11 Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia. J Gen Intern Med 2012 1.83
12 Out-of-pocket medication costs and use of medications and health care services among children with asthma. JAMA 2012 1.83
13 The health and cost consequences of obesity among the future elderly. Health Aff (Millwood) 2005 1.79
14 Hospital spending and inpatient mortality: evidence from California: an observational study. Ann Intern Med 2011 1.79
15 Growing Internet use may help explain the rise in prescription drug abuse in the United States. Health Aff (Millwood) 2011 1.71
16 Impact of specialty drugs on the use of other medical services. Am J Manag Care 2008 1.51
17 Three large-scale changes to the Medicare program could curb its costs but also reduce enrollment. Health Aff (Millwood) 2013 1.50
18 U.S. pharmaceutical policy in a global marketplace. Health Aff (Millwood) 2008 1.47
19 Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med 2009 1.41
20 Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates. Health Aff (Millwood) 2012 1.38
21 Pharmacy benefit caps and the chronically ill. Health Aff (Millwood) 2007 1.28
22 Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. Health Serv Res 2010 1.27
23 Disability and health care spending among medicare beneficiaries. Health Aff (Millwood) 2005 1.26
24 The lifetime burden of chronic disease among the elderly. Health Aff (Millwood) 2005 1.23
25 HIV care providers emphasize the importance of the Ryan White Program for access to and quality of care. Health Aff (Millwood) 2014 1.21
26 An economic evaluation of the war on cancer. J Health Econ 2010 1.13
27 The promise of health care cost containment. Health Aff (Millwood) 2007 1.13
28 The effect of regulation on pharmaceutical revenues: experience in nineteen countries. Health Aff (Millwood) 2008 1.13
29 Undiagnosed disease, especially diabetes, casts doubt on some of reported health 'advantage' of recent Mexican immigrants. Health Aff (Millwood) 2012 1.08
30 Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population. Diabetes Technol Ther 2012 1.07
31 The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment. Health Aff (Millwood) 2012 1.01
32 Digesting the doughnut hole. J Health Econ 2013 1.00
33 Medicare Part D: a successful start with room for improvement. JAMA 2008 0.99
34 Medicare part D after 2 years. Am J Manag Care 2009 0.99
35 The Disability burden of COPD. COPD 2012 0.97
36 Impact of oral nutritional supplementation on hospital outcomes. Am J Manag Care 2013 0.97
37 How costly is hospital quality? A revealed-preference approach. J Ind Econ 2011 0.96
38 Identifying potential health care innovations for the future elderly. Health Aff (Millwood) 2005 0.96
39 Spending and mortality in US acute care hospitals. Am J Manag Care 2013 0.93
40 The potential impact of comparative effectiveness research on U.S. health care expenditures. Demography 2010 0.93
41 The prospect of a generation free of HIV may be within reach if the right policy decisions are made. Health Aff (Millwood) 2014 0.92
42 Physician prescribing behavior and its impact on patient-level outcomes. Am J Manag Care 2011 0.91
43 The changing face of pharmacy benefit design. Health Aff (Millwood) 2004 0.90
44 Nearly 60,000 uninsured and low-income people with HIV/AIDS live in states that are not expanding Medicaid. Health Aff (Millwood) 2014 0.90
45 Technological advances in cancer and future spending by the elderly. Health Aff (Millwood) 2005 0.90
46 Data-driven decision-making tools to improve public resource allocation for care and prevention of HIV/AIDS. Health Aff (Millwood) 2014 0.90
47 Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychotics. Health Aff (Millwood) 2011 0.89
48 Disability forecasts and future Medicare costs. Front Health Policy Res 2004 0.88
49 Hospital costs and inpatient mortality among children undergoing surgery for congenital heart disease. Health Serv Res 2013 0.86
50 Racial and ethnic disparities in hospital care resulting from air pollution in excess of federal standards. Soc Sci Med 2011 0.86
51 Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD. Curr Med Res Opin 2012 0.85
52 Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996-2009. Health Aff (Millwood) 2014 0.85
53 Coverage and preventive screening. Health Serv Res 2010 0.85
54 Association between the birth of twins and parental divorce. Obstet Gynecol 2011 0.83
55 Diabetes management for low-income patients in Los Angeles: two strategies improved disease control in the short term. Health Aff (Millwood) 2012 0.83
56 The value of medical and pharmaceutical interventions for reducing obesity. J Health Econ 2012 0.82
57 Prescription medication abuse and illegitimate internet-based pharmacies. Ann Intern Med 2011 0.81
58 Measuring the value of better diabetes management. Am J Manag Care 2013 0.81
59 Early HIV treatment led to life expectancy gains valued at $80 billion for people infected in 1996-2009. Health Aff (Millwood) 2014 0.80
60 A socioeconomic profile of older adults with HIV. J Health Care Poor Underserved 2005 0.80
61 Did Medicare Part D reduce disparities? Am J Manag Care 2015 0.79
62 An economic analysis of conservative management versus active treatment for men with localized prostate cancer. J Natl Cancer Inst Monogr 2012 0.79
63 Do Statins Reduce the Health and Health Care Costs of Obesity? Pharmacoeconomics 2015 0.78
64 Drug costs and out-of-pocket spending in cancer clinical trials. Contemp Clin Trials 2007 0.78
65 Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid. Am J Manag Care 2014 0.78
66 Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs. Health Aff (Millwood) 2012 0.77
67 Medication adherence and measures of health plan quality. Am J Manag Care 2015 0.77
68 A new method for determining patient payments for outpatient drugs. Am J Manag Care 2002 0.75
69 Response to Epstein's comment on "heterogeneity in action". Health Econ 2014 0.75
70 A response to the points by Manton and Williamson. Med Care 2003 0.75
71 Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens. Am J Manag Care 2012 0.75
72 The Impact of Air Quality on Hospital Spending. Rand Health Q 2012 0.75
73 Using Self-reports or Claims to Assess Disease Prevalence: It's Complicated. Med Care 2017 0.75
74 Value of improved lipid control in patients at high risk for adverse cardiac events. Am J Manag Care 2016 0.75